National survey of value of plasma standards for anticoagulant therapy.
作者信息
Poller L, Thomson J M
出版信息
Br Med J. 1968 Apr 13;2(5597):88-90. doi: 10.1136/bmj.2.5597.88.
Abstract
摘要
相似文献
1
National survey of value of plasma standards for anticoagulant therapy.抗凝治疗血浆标准价值的全国性调查。
Br Med J. 1968 Apr 13;2(5597):88-90. doi: 10.1136/bmj.2.5597.88.
2
Standardization of the one-stage prothrombin time test for the control of anticoagulant therapy: availability and use of thromboplastin reference preparations.用于抗凝治疗控制的一步法凝血酶原时间试验的标准化：凝血活酶参考制剂的可用性及使用
Br Med J. 1971 Aug;3(5772):470-1. doi: 10.1136/bmj.3.5772.470.
3
Control of anticoagulants.抗凝剂的控制
Br Med J. 1969 Oct 18;4(5676):125-6.
4
[Standardized prothrombin time test for control of anticoagulant therapy].[用于抗凝治疗控制的标准化凝血酶原时间检测]
Lakartidningen. 1971 Jun 21;68(30):3373-4.
5
Control of anticoagulant treatment.抗凝治疗的控制
Lancet. 1969 Nov 8;2(7628):990-1.
6
Control of oral anticoagulant treatment.口服抗凝治疗的控制
Br Med J. 1971 Nov 6;4(5783):317-8.
7
8
Standardization of oral anticoagulant therapy.口服抗凝治疗的标准化
Med J Aust. 1984 Jun 23;140(13):804. doi: 10.5694/j.1326-5377.1984.tb132648.x.
9
Standardization of laboratory tests for controlling anticoagulent therapy.用于控制抗凝治疗的实验室检测标准化
Am J Clin Pathol. 1970 Mar;53(3):348-54. doi: 10.1093/ajcp/53.3.348.
10
Has the time arrived to replace the quick prothrombin time test for monitoring oral anticoagulant therapy?
Clin Chem. 2005 Mar;51(3):483-5. doi: 10.1373/clinchem.2004.045393.
引用本文的文献
1
Identification of a congenital defect of factor VII in a colony of beagle dogs: the clinical use of the plasma.比格犬群体中凝血因子 VII 先天性缺陷的鉴定：血浆的临床应用。
J Clin Pathol. 1971 Oct;24(7):626-32. doi: 10.1136/jcp.24.7.626.
2
The "therapeutic range" of the one-stage prothrombin time in the control of anticoagulant therapy: the effect of different thromboplastin preparations.一期凝血酶原时间在抗凝治疗控制中的“治疗范围”：不同凝血活酶制剂的影响
Can Med Assoc J. 1971 Nov 20;105(10):1041-3 passim.
3
[Activity of reagents for thromboplastin-time determination (Quick test) of various manufacturers in changing concentrations of several blood coagulation factors].[不同厂家凝血活酶时间测定试剂（Quick试验）在几种凝血因子浓度变化时的活性]
Blut. 1972 May;24(5):303-13. doi: 10.1007/BF01642015.
4
Etiology of breast cancer. II. Epidemiologic aspects.乳腺癌的病因。II. 流行病学方面。
Can Med Assoc J. 1973 Aug 4;109(3):201-6.
本文引用的文献
1
STANDARDIZATION OF ANTICOAGULANT TREATMENT: THE MANCHESTER REGIONAL THROMBOPLASTIN SCHEME.抗凝治疗的标准化：曼彻斯特地区凝血活酶方案
Br Med J. 1964 Aug 29;2(5408):565-6. doi: 10.1136/bmj.2.5408.565.
2
1963 prothrombin time test survey, College of American Pathologists, Standards Committee, Subcommittee on Coagulation.1963年凝血酶原时间检测调查，美国病理学家学会，标准委员会，凝血小组委员会
Am J Clin Pathol. 1967 Jan;47(1):40-59. doi: 10.1093/ajcp/47.1.40.
3
Standardization of the one-stage prothrombin time for the control of anticoagulant therapy.用于抗凝治疗控制的一步法凝血酶原时间标准化。
Br Med J. 1967 Jan 14;1(5532):84-8. doi: 10.1136/bmj.1.5532.84.
4
A national standard for anticoagulant therapy. The Manchester comparative reagent.抗凝治疗的国家标准。曼彻斯特比较试剂。
Lancet. 1967 Mar 4;1(7488):491-3. doi: 10.1016/s0140-6736(67)91109-9.
Zotero 插件